Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Hemorrhage 12Neoplasms 7Leiomyoma 6Breast Neoplasms 6Thrombocytopenia 3Postoperative Hemorrhage 3Meningioma 3Hematologic Neoplasms 3Urinary Bladder Neoplasms 2Seroma 2Seizures 2Prostatic Neoplasms 2Myofibroma 2Menorrhagia 2Brain Neoplasms 2Bone Neoplasms 2Blood Loss, Surgical 2Wrist Fractures 1Urologic Diseases 1Urinary Tract Infections 1Urinary Retention 1Thromboembolism 1Stomach Neoplasms 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Skin Neoplasms 1Sepsis 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1

Interventions

Surveys and Questionnaires 3delta 24-sterol reductase 2Urinary Diversion 2Surgical Procedures, Operative 2Vascular Access Devices 1Uterine Artery Embolization 1Tranexamic Acid 1Telemedicine 1Propofol 1Pilot Projects 1Patient Transfer 1Parapsychology 1Music Therapy 1Midazolam 1Mastectomy, Segmental 1Lidocaine 1Lead 1Imiquimod 1Ibuprofen 1Fentanyl 1Exercise 1Drainage 1Cystectomy 1Control Groups 1Colonoscopy 1Bandages, Hydrocolloid 1Anesthesia, Local 1Aftercare 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Patient Satisfaction × Tranexamic Acid × Clear all
NCT04555343 2021-11-05

Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention

Fraser Health

Phase 1/2 Completed
14 enrolled
Genitourinary

Urinary Bladder Neoplasms, Hematuria, Prostatic Neoplasms, Urologic Diseases, Urinary Retention, Patient Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡